Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Annals of Surgery
|
August 3, 2020
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma
Syed A Ahmad, Mai Duong, Davendra P S Sohal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 27, 2022
Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes
Ahmed M Elamir, John D Karalis, Nina Niu Sanford, et al.
JAMA Network Open
|
January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial
Brandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Cancers
|
January 12, 2021
Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial
Salomon M Stemmer, Nebojsa S Manojlovic, Mihai Vasile Marinca, et al.
JAMA Network Open
|
April 12, 2024
Remote Monitoring and Data Collection for Decentralized Clinical Trials
Bobby Daly, Otis W Brawley, Mary K Gospodarowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
The New England Journal of Medicine
|
January 10, 2024
Repotrectinib in <i>ROS1</i> Fusion-Positive Non-Small-Cell Lung Cancer
Alexander Drilon, D Ross Camidge, Jessica J Lin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Annals of Surgery
|
August 3, 2020
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma
Syed A Ahmad, Mai Duong, Davendra P S Sohal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 27, 2022
Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes
Ahmed M Elamir, John D Karalis, Nina Niu Sanford, et al.
JAMA Network Open
|
January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial
Brandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Cancers
|
January 12, 2021
Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial
Salomon M Stemmer, Nebojsa S Manojlovic, Mihai Vasile Marinca, et al.
JAMA Network Open
|
April 12, 2024
Remote Monitoring and Data Collection for Decentralized Clinical Trials
Bobby Daly, Otis W Brawley, Mary K Gospodarowicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
The New England Journal of Medicine
|
January 10, 2024
Repotrectinib in <i>ROS1</i> Fusion-Positive Non-Small-Cell Lung Cancer
Alexander Drilon, D Ross Camidge, Jessica J Lin, et al.
Page
of 4